Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
[DOI] [PubMed] [Google Scholar] 281.Cohen F., Mills D., Chesak J
As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
The discontinuation rate due to side effects was 11.2% at the highest dose, meaning nearly 9 out of 10 people tolerated the medication through the full trial period
Overall, GLP-1 users are mostly Gen X, African American, or Hispanic and have lower incomes than non-users
15 September 2023 5 min read by The Conversation Many of the drugs we use today started their journey from bench to bedside in a computer
US$ 20.45
US$ 21.35
US$ 27.72
US$ 23.90
